Obesity Trial, Recruiting NCT06770049 Sponsor: Mayo Clinic Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06770049
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men or women between 18 and 65 years old who have obesity, meaning a BMI (body mass index) above 30 kg/m²

Who may not be able to join:

  • People whose weight has changed by more than 3% in the past 3 months
  • People who have previously had weight-loss surgery or a weight-loss procedure done through an endoscope (a camera inserted into the stomach)
  • People who have untreated mental health conditions, including binge eating disorder or bulimia
  • People who are currently using anti-obesity medications
  • People who have used any medications that affect weight, appetite, or energy levels in the past 6 months
  • People with a history of type 1 diabetes, or who have other medical conditions that are not well controlled (for example, high blood pressure that is not being managed)
  • Women who are pregnant or planning to become pregnant
  • People who have any condition that would limit their ability to fully take part in the study
  • People excluded at the discretion of the lead researcher overseeing the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andres Acosta, MD,PhD, Mayo Clinic

Phone: 507-266-6004

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
22 January 2025
Est. completion
1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Total Body Weight Loss (TBWL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov